Rate of early treatment discontinuation among a community sample of naive hepatitis C patients on Rebetron combination therapy.

被引:0
|
作者
Belville-Robertson, TL
Brown, KA
Moonka, DK
Mahr, G
Clemensen, LR
Mankato, N
Lucas, MB
Eshelman, AK
机构
[1] Henry Ford Hlth Syst, Detroit, MI USA
[2] ISJ Clin Northridge, N Mankato, MN USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1716
引用
收藏
页码:601A / 601A
页数:1
相关论文
共 50 条
  • [1] Influence of patient gender on the length of treatment leading to the successful elimination of hepatitis C with rebetron combination therapy.
    Gajula, L
    Clark, C
    HEPATOLOGY, 2000, 32 (04) : 567A - 567A
  • [2] Early phase hepatitis C virus (HCV) load response to Rebetron® therapy.
    Anderson, FH
    Rock, N
    Walston, LL
    Gunadasa, K
    Cook, P
    Hill, WD
    Krajden, M
    HEPATOLOGY, 2000, 32 (04) : 556A - 556A
  • [3] Treatment of chronic hepatitis C: impact of combination therapy.
    Davis G.L.
    Current Gastroenterology Reports, 1999, 1 (1) : 9 - 14
  • [4] Continuous combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Cantu, NS
    Kadakia, SC
    HEPATOLOGY, 2001, 34 (04) : 585A - 585A
  • [5] Induction treatment with combination therapy results in a lower relapse rate in naive patients with chronic hepatitis C.
    Rothstein, KD
    Pena, RE
    Suvannasankha, A
    DiGregorio, K
    Manzarbeitia, C
    Reich, DJ
    Bond, K
    Gross, F
    Shaw, E
    Peikin, S
    Mushnick, A
    Munoz, SJ
    HEPATOLOGY, 2000, 32 (04) : 560A - 560A
  • [6] Low dose inteferon-ribavirin therapy is as efficacious as regular strength rebetron® for the treatment of naive hepatitis C patients.
    Bernstein, DE
    Tiev, M
    Steinberg, SE
    GASTROENTEROLOGY, 2000, 118 (04) : A1425 - A1425
  • [7] Efficacy of Rebetron (interferon and ribavirin) combination therapy in the treatment of patients with chronic hepatitis C not previously treated with interferon.
    Nelson, JB
    HEPATOLOGY, 2000, 32 (04) : 553A - 553A
  • [8] Hepatic steatosis in hepatitis C patients: Steatosis decreases with combination therapy.
    Hepburn, MJ
    Lawitz, EJ
    Torgerson, S
    HEPATOLOGY, 2002, 36 (04) : 605A - 605A
  • [9] Antiviral therapy for treatment naive patients with hepatitis C virus
    Oh, S
    Afdhal, NH
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 497 - +
  • [10] Efficacy and safety of "sandwich" therapy (initial Interferon induction with end-treatment Interferon boost) with Rebetron in the treatment of naive patients with chronic hepatitis C.
    Bassan, I
    Bloom, ML
    Phillips, RS
    Muirhead, S
    Garrison, S
    HEPATOLOGY, 2001, 34 (04) : 597A - 597A